FTX Leads Distressed Crypto Buyouts, But Who Else Can Follow?

By | June 28, 2022

I’m glad I decided to wait though—Monday afternoon, Bloomberg reported that FTX was thinking about making a play for Robinhood, the publicly traded stock trading app currently worth $8 billion. This is on top of FTX extending Blockfi a $250 million credit line and lending Voyager Digital $485 million consisting of cash and bitcoin through…

Read More

Terpene testing for all, taxes and transparency, and where we’ll be next year.

By Jay | June 28, 2022

So, I’ll be honest y’all. I am basically on board the “terpenes are overhyped” train.  And it’s NOT because I don’t think that terpenes are valuable. It’s because I see some people placing way too much emphasis on terpenes and forgetting about cannabinoids, enzymes, and the countless other chemical reactions that happen when cannabis meets our body.  Overhyped. Not unimportant.  Terpenes…

Read More

Deel: An Acquisition From Down Under

By | June 27, 2022

Hey everyone! Over the weekend, I watched the movie “Margin Call.”  I definitely enjoyed it but could not stop thinking just how much better it could have been. The Big Short is much better!  Also – for those wondering, the second Invitae piece is dropping on Thursday! Get pumped.  Showtime! Want to get these in…

Read More

Finding Money and Managing Paperwork

By Alex Johnson | June 27, 2022

3 Fintech News Stories #1: Finding Money and Managing Paperwork What happened? A new fintech company called Aidaly came out of stealth: Caring for a family member is not only hard work, but expensive, too. Many family caregivers miss work (or stop working) and pay for medical expenses out of pocket. Aidaly was created to…

Read More

Unwarranted Clinical Variation

By workweek | June 27, 2022

Same age. Same sex. Same illness. Different treatment. This is unwarranted clinical variation; it’s care that’s not consistent with a patient’s preference or related to a patient’s underlying illness. The U.S. has a significant problem with unwarranted clinical variation, stemming from its inherent complexity. This isn’t a benign problem, though. The sequelae of such variation include…

Read More